Hao Feiran, Pang Xu, Xu Kaikun, Wang Meixi, Ma Zengchun, Tan Hongling, Han Lifeng, Chang Cheng, Chen Ming, Huang Zhanwen, Gao Yue
Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Lifeomics, National Center for Protein Sciences (Beijing), Beijing 102206, China.
Evid Based Complement Alternat Med. 2022 Mar 11;2022:7565177. doi: 10.1155/2022/7565177. eCollection 2022.
In recent years, many traditional Chinese medicine injections based on saponin (PNS) have been reported to cause anaphylaxis. Previous studies on the anaphylactic saponins of PNS and their mechanism are inadequate. In this study, potential anaphylactic saponins were obtained by the separation of PNS and preparation of each individual component through comprehensive techniques, such as liquid chromatography, preparative chromatography, HPLC, NMR, and MS. The anaphylactic abilities of these saponins were tested using RBL-2H3 cells via a -hexosaminidase release rate test. The results for the mechanism of anaphylaxis were obtained by a proteomic analysis using RBL-2H3 cells. The results indicate that, among all the saponins prepared, gypenoside LXXV and notoginsenoside T5 showed strong anaphylactic abilities and notoginsenoside ST-4 and ginsenoside Rk3 showed weak anaphylactic abilities. These 4 saponins can induce anaphylaxis via direct stimulation of effector cells. The gene oncology enrichment analysis results showed that, among these saponins, only gypenoside LXXV was related to organelles of the endoplasmic reticulum and Golgi apparatus and biological processes in response to organic cyclic compounds. Four proteins in RBL-2H3 cells with the accession numbers A0A0G2JWQ0, D3ZL85, D4A5G8, and Q8K3F0 were identified as crucial proteins in the anaphylactic process. This research will help traditional Chinese medicine injection manufacturers strengthen their quality control and ensure the safety of anaphylactic saponins.
近年来,许多基于皂苷(三七总皂苷)的中药注射剂被报道可引起过敏反应。以往关于三七总皂苷的过敏性皂苷及其机制的研究并不充分。在本研究中,通过液相色谱、制备色谱、高效液相色谱、核磁共振和质谱等综合技术对三七总皂苷进行分离并制备各个组分,从而获得潜在的过敏性皂苷。使用RBL-2H3细胞通过β-己糖胺酶释放率试验检测这些皂苷的过敏能力。通过对RBL-2H3细胞进行蛋白质组学分析获得过敏反应机制的结果。结果表明,在所有制备的皂苷中,绞股蓝皂苷LXXV和三七皂苷T5表现出较强的过敏能力,三七皂苷ST-4和人参皂苷Rk3表现出较弱的过敏能力。这4种皂苷可通过直接刺激效应细胞诱导过敏反应。基因本体富集分析结果表明,在这些皂苷中,只有绞股蓝皂苷LXXV与内质网和高尔基体细胞器以及对有机环状化合物的生物过程有关。RBL-2H3细胞中登录号为A0A0G2JWQ0、D3ZL85、D4A5G8和Q8K3F0的4种蛋白质被鉴定为过敏过程中的关键蛋白质。本研究将有助于中药注射剂制造商加强质量控制,确保过敏性皂苷的安全性。